To improve public health and handle stunting issues in South Sulawesi, Dexa Group donated Indonesian Indigenous Modern Medicines (OMAI). The OMAI donation was symbolically handed over during the OMAI Expedition at the Bangga Buatan Indonesia & Bangga Wisata Indonesia Sulawesi Selatan 2022 South Sulawesi 2022 event at Losari Beach Pavilion, Makassar, Thursday, February 24, 2022.

Dexa Group Corporate Affairs Director Mr. Krestijanto Pandji held a ceremony by departing the OMAI Expedition Pinisi at the Losari Pavilion, together with the Coordinating Minister for Maritime and Investment Affairs of the Republic of Indonesia General TNI Luhut Binsar Pandjaitan, Minister of Tourism and Creative Economy Mr. Sandiaga Salahuddin Uno, Acting Governor of South Sulawesi Mr. Andi Sudirman Sulaiman, and Head of the Goods/Services Procurement Policy Institute, Mr. Abdullah Azwar Anas.

In the event, Dexa Group donated medicines using the Pinisi ship, an icon of the Bugis (Makassar) community, that sailed to Galesong Harbor, Takalar Regency. The Pinisi ship carried OMAI products, including the immune supplement STIMUNO, cough medicine HerbaKOF, and the high-quality breast milk supplement made from katuk leaves, torbangun leaves, and cork fish HerbaASIMOR.

“South Sulawesi is not only dealing with health problems, but we are also taking precautions, especially during the pandemic, on stunting cases. Therefore, we appreciated Dexa Group for contributing to providing donations to improve the health of the people of South Sulawesi,” said Plt. Governor of South Sulawesi Mr. Andi Sudirman.

Dexa Group’s Corporate Affairs Director, Mr. Krestijanto Pandji, said that the donation of OMAI was part of the Dexa Group’s Corporate Social Responsibility (CSR) program. “Through OMAI’s donation for public health as well as the stunting management program, we hope that the community will be more proud to use products made in Indonesia,” said Mr. Krestijanto.

Contribution of Indonesian Indigenous Modern Medicines for National Pharmacy Independence

Meanwhile, Minister for Maritime and Investment Affairs, Mr. Luhut Binsar Panjaitan, emphasized that the government, including local governments, needs to support domestic products. In the health sector, supporting domestic medicinal products for national pharmaceutical independence and resilience needs to be implemented by adding Indonesian Indigenous Modern Medicines (OMAI) made from Indonesian natural ingredients in the National Formulary to be used in the National Health Insurance (JKN) program.

Mr. Luhut said phytopharmaceutical OMAI should be encouraged to be included in the National Health Insurance System. “This is a part of the government’s support to the national pharmaceutical manufacturers who have dedicated themselves to researching, developing, and producing domestic medicines with high Domestic Component Level (TKDN). This support is necessary to realize national pharmaceutical independence,” said Mr. Luhut at Bangga Buatan Indonesia & Bangga Wisata Indonesia (BBI & BWI) South Sulawesi (Sulsel) 2022 event on Thursday, February 24, 2022, in Losari Beach Pavilion, Makassar.

Deputy for Tourism and Creative Economy at the Coordinating Ministry for Maritime Affairs and Investment, Mr. Odo RM Manuhutu, added that the development of medicines from Indonesia’s natural raw materials plays a significant role in maximizing the employment of Indonesia’s diverse and abundant innate potentials.

“Indonesia’s biodiversity is the second largest globally but is ranked 19th as an exporting country for herbal medicines, far below the Netherlands with 6.05% in third place, China 27.54% in second place, and India 33.46% in the first place. The Bangga Buatan Indonesia program should be momentum for Indonesian Modern Medicine to be promoted in their own country,” said Mr. Odo at OMAI Expedition, which is a part of the BBI & BWI South Sulawesi 2022 event.

Mr. Odo continued the contribution of Indonesian Original Modern Medicine to revive the community’s economy needs to be highlighted. “MSMEs and farmers who cultivate medicinal plants, fish, and worms that are used as raw materials for medicine, will experience a huge economic impact. If OMAI is encouraged to be included in the National Health Insurance, then MSMEs and farmers will be more prosperous. Indeed, this will escalate agro-tourism in the regions,” said Mr. Odo.